Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03EDD
|
||||
Former ID |
DIB016702
|
||||
Drug Name |
VN/107-1
|
||||
Synonyms |
CYP17 inhibitors (prostate cancer); CYP17 inhibitors (prostate cancer), University of Maryland; VN/107-1; VN/108-1; VN/109-1; VN/125-1; VN/85-1; VN/87-1
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Investigative | [543411] | ||
Company |
University of Maryland
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@H]12[C@H]3[C@@H]([C@@]4(C(=CC3)C[C@H](CC4)O)C)CC[C@@<br />]1(C(=CC2)n1ccnc1)C
|
||||
CAS Number |
CAS 203503-62-2
|
||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [543411] | |
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.